Cells with low levels of bioavailable Cu or Fe are susceptible to selective killing by chelation therapy to reduce Cu or Fe-dependent cell growth and proliferation, revealing a disease-relevant metal landscape that can be leveraged for new therapeutics chemistry.princeton.edu/news/chang-l... 2/end
